Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

ACUTE MYELOID LEUKEMIA

Evaluating concordance in assessment of ECOG performance status in acute myeloid leukemia patients

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Walter RB, Othus M, Borthakur G, Ravandi F, Cortes JE, Pierce SA, et al. Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. J Clin Oncol. 2011;29:4417–23.

    Article  Google Scholar 

  2. Laribi K, Sobh M, Ghez D, Baugier de Materre A. Impact of age, functional status, and comorbidities on quality of life and outcomes in elderly patients with AML: review. Ann Hematol. 2021;100:1359–76.

    Article  Google Scholar 

  3. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;6:649–55.

  4. McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22:276–82.

    Article  Google Scholar 

  5. Cohen’s Kappa Statistic. 2017. https://www.statisticshowto.datasciencecentral.com/cohens-kappa-statistic.

  6. Ziai A. Inter-rater agreement Kappas. Towards data science. 2017. https://towardsdatascience.com/inter-rater-agreement-kappas-69cd8b91ff75.

  7. Abel GA, Klepin HD. Frailty and the management of hematologic malignancies. Blood. 2018;131:515–24.

    CAS  Article  Google Scholar 

  8. Loh KP, Tooze JA, Nicklas BJ, Kritchevsky SB, Williamson JD, Ellis LR, et al. Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia. J Geriatr Oncol. 2020;11:410–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

NM was responsible for data collection, data analysis, and writing the report. CS contributed to data collection. RBW and MEMP interpreted results and provided feedback on the report. EHE conceived of the project and provided critical analysis and feedback on the report: we continue to miss his knowledge and leadership in the field of AML.

Corresponding author

Correspondence to Mary-Elizabeth M. Percival.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mostofi, N., Shaw, C., Walter, R.B. et al. Evaluating concordance in assessment of ECOG performance status in acute myeloid leukemia patients. Leukemia (2022). https://doi.org/10.1038/s41375-022-01664-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41375-022-01664-4

Search

Quick links